Teva to sell Quebec plant, transfer 150 jobs; FTC studies PBM merger for impact on specialty pharma;

@FiercePharma: Who could make a play for Amylin next? AstraZeneca and Sanofi, per analysts. Bristol-Myers may return, too. Article | Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) is selling a Quebec plant to contract manufacturer Halo Pharmaceuticals; 150 jobs will transfer as well. Item

> The Federal Trade Commission is studying how the merger of Express Scripts ($ESRX) and Medco Health Solutions ($MHS) would affect availability and pricing of specialty drugs. Article

> Big Pharma spends €40 million a year lobbying decision-makers in the EU. Report

> Horizon Pharma sued Par Pharmaceuticals ($PRX) for patent infringement after the latter asked the FDA to approve a copycat version of the arthritis pill Duexis. Story

> Standard & Poor's assigned an A- rating to Teva Pharmaceutical Industries' proposed senior unsecured notes. Item

> India's Aurobindo Pharma joins the crowd of generics makers with an approved version of AstraZeneca's ($AZN) newly off-patent antipsychotic Seroquel. News

Biotech News

@FierceBiotech: Who thinks they've got the tonic for Big Pharma social media headaches? This guy does: Piece | Follow @FierceBiotech

@JohnCFierce: VC boom: U.K. charity births $80M biotech fund for cancer drug research--I count $730M in new U.K./euro funds this month. Story | Follow @JohnCFierce

@RyanMFierce: Moscow backs clones of Western biotech programs in Russia. More | Follow @RyanMFierce

@FierceMedDev: Roche raises bid for U.S. diagnostics firm Illumina - San Jose Mercury News. Article | Follow @FierceMedDev

> Optimer inks $90M C. difficile drug pact with Astellas. News

> Cetero preps for new owner after filing for bankruptcy protection. Item

> Is an Amylin takeover inevitable after the BMS rejection? More

Manufacturing News

> CMC, third-party manufacturing issues delay Map drug launch. News

> California implant makers get FDA warnings. Article

> Novartis plant disruptions affect pet treatments. Story

> Sandoz Canada president explains shortages to House of Commons. Article

> Halo agrees to buy Teva's Montreal facility. Report

CRO News

> Parexel should see more revenue, higher share prices, analysts say. More

> Cetero sees strong future despite bankruptcy protection filing. Article

> INC Research axes staffers, closes Connecticut lab. Story

> Spaulding's hand-held ECG fuels tax credits and hiring boom. Item

> Report sheds light on pharma and CRO trial enrollment woes. News

Vaccines News

> Vaxfectin-based malaria vaccine could stop transmission. Item

> Narcolepsy spike linked with flu shot. Story

> Academics' oral stomach flu vax could save lives. Article

> Genetic tweaking could create Chlamydia vaccine. More

And Finally... Adding electricity to acupuncture may serve as an add-on treatment for depression, researchers found. Report